Department of Nursing, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, 050000, China.
Department of Gynecology, Shijiazhuang Obstetrics and Gynecology Hospital, No. 206 East Zhongshan Road, Shijiazhuang, 050000, China.
Ir J Med Sci. 2024 Apr;193(2):595-604. doi: 10.1007/s11845-023-03501-8. Epub 2023 Sep 1.
Cognitive behavioral stress management (CBSM) modifies individuals' maladaptive cognition and improves their ability in managing stress. The present study was to inquire about the utility of CBSM in mental health and quality of life in patients with cervical cancer.
Totally, 172 postoperative cervical cancer patients were randomly classified into CBSM (N=86) and normal care group (N=86) to receive 8-week CBSM and normal care, correspondingly. Self-rating anxiety/depression scale (SAS/SDS), EuroQol-5 dimensions (EQ-5D), EuroQol-visual analogue scale (EQ-VAS), and quality of life questionnaire-core 30 (QLQ-C30) scores were evaluated at discharge (M0), 1 month (M1), M3, and M6 after discharge.
SAS scores at M6 (P=0.003), M1 (P=0.042), and M3 (P=0.010), and the proportion of patients with SAS-defined anxiety at M3 (P=0.040) and M6 (P=0.019) were reduced in CBSM group versus normal care group. SDS scores at M3 (P=0.020) and M6 (P=0.016), and the proportion of patients with SDS-defined depression at M6 (P=0.036) was descended in CBSM group versus normal care group. EQ-VAS score at M1 (P=0.044), M3 (P=0.014), and M6 (P=0.002) were increased, while EQ-5D score at M3 (P=0.030) was descended in CBSM group versus normal care group. Meanwhile, QLQ-C30 global health status score at M1 (P=0.046), M3 (P=0.037), and M6 (P=0.007), QLQ-C30 function score at M3 (P=0.033) and M6 (P=0.016) were ascended, but QLQ-C30 symptom score at M3 (P=0.042) was declined in CBSM group versus normal care group.
CBSM is an effective intervention for decreasing anxiety and depression, and improving quality of life in patients with cervical cancer.
认知行为应激管理（CBSM）可改变个体的适应不良认知，提高其应激管理能力。本研究旨在探讨 CBSM 在宫颈癌患者心理健康和生活质量中的应用价值。
将 172 例宫颈癌术后患者随机分为 CBSM 组（N=86）和常规护理组（N=86），分别接受 8 周 CBSM 和常规护理。在出院时（M0）、1 个月（M1）、3 个月（M3）和 6 个月（M6）后评估患者的自评焦虑/抑郁量表（SAS/SDS）、欧洲五维健康量表（EQ-5D）、EQ-视觉模拟量表（EQ-VAS）和生活质量核心问卷 30 项（QLQ-C30）评分。
CBSM 组患者 M6 时的 SAS 评分（P=0.003）、M1 时的 SAS 评分（P=0.042）、M3 时的 SAS 评分（P=0.010）以及 M3 时 SAS 定义的焦虑患者比例（P=0.040）和 M6 时 SAS 定义的焦虑患者比例（P=0.019）均低于常规护理组。CBSM 组患者 M3 时的 SDS 评分（P=0.020）、M6 时的 SDS 评分（P=0.016）以及 M6 时 SDS 定义的抑郁患者比例（P=0.036）均低于常规护理组。CBSM 组患者 M1 时的 EQ-VAS 评分（P=0.044）、M3 时的 EQ-VAS 评分（P=0.014）、M6 时的 EQ-VAS 评分（P=0.002）升高，M3 时的 EQ-5D 评分（P=0.030）降低。同时，CBSM 组患者 M1 时的 QLQ-C30 整体健康状况评分（P=0.046）、M3 时的 QLQ-C30 整体健康状况评分（P=0.037）、M6 时的 QLQ-C30 整体健康状况评分（P=0.007）、M3 时的 QLQ-C30 功能评分（P=0.033）和 M6 时的 QLQ-C30 功能评分（P=0.016）升高，而 M3 时的 QLQ-C30 症状评分（P=0.042）降低。
CBSM 是一种有效的干预措施，可降低宫颈癌患者的焦虑和抑郁水平，提高其生活质量。
